Ventilator-associated pneumonia (VAP) is a common nosocomial infection
Ventilator-associated pneumonia (VAP) is a common nosocomial infection causing significant morbidity and mortality. Consequently, accurate and timely diagnosis is essential for improving patient outcomes. VAP is generally defined as pneumonia in a mechanically ventilated patient with onset 48 h or more after hospital admission. The use of clinical criteria, e.g., fever, purulent tracheal secretions, leukocytosis, and radiographic findings, is unreliable for the diagnosis of VAP and has been associated with inappropriate or inadequate antimicrobial therapy (3) . Quantitative bacterial culture of lower respiratory tract secretions is now commonly utilized for the confirmation of clinically suspected VAP. However, the most efficient strategy for establishing a bacteriological diagnosis remains controversial.
Several techniques for obtaining samples from the lower respiratory tract for microbiological analysis have been evaluated. Johanson et al. (6) compared cultures of tracheal aspirates, bronchoalveolar lavage (BAL) fluid, protected-specimen brush (PSB) samples, and direct lung aspirates with cultures of lung homogenates and histological findings for mechanically ventilated baboons and showed that BAL provided the most accurate reflection of the lungs' bacterial burden. Similarly, both BAL and PSB have been shown to be reliable for the identification of microorganisms present in the lung specimens of patients with bacterial pneumonia (2, 15) . Compared to a diagnostic strategy based on clinical criteria, an approach utilizing quantitative culture results obtained by PSB or BAL has been associated with earlier attenuation of organ dysfunction and less use of antimicrobial agents for patients with suspected VAP (4) . Moreover, the American Thoracic Society and the Infectious Diseases Society of America have issued evidencebased guidelines that support the use of quantitative culture of bronchoscopically collected lower respiratory tract secretions for the etiologic diagnosis of VAP (1) .
Although fiber optic bronchoscopy allows direct access to the lower respiratory tract for the sampling of bronchial and parenchymal tissues, the bronchoscope must first traverse the endotracheal tube or oropharynx. In ventilated patients, the endotracheal tube often becomes colonized with potential pathogens that may contaminate the lower airway sample during bronchoscopic BAL collection (7) . Therefore, a specific bacteriological threshold has been established to diagnose VAP from bacterial cultures of BAL fluid. Torres and ElEbiary (11) reviewed 23 studies evaluating bronchoscopic BAL methods and reported that 10 4 CFU/ml was the most frequent cutoff used to differentiate colonization from infection.
While bronchoscopy is important for obtaining minimally contaminated specimens for bacterial culture from patients who cannot produce sputum, the procedure is invasive and costly. Clinical hypoxemia is a frequent complication of this technique and poses a particularly high risk to patients with acute respiratory distress syndrome (ARDS) (12) . Furthermore, the BAL procedure is more time-consuming than simple bronchoscopy and has been associated with more severe adverse affects. The sampling of both lungs by BAL has the potential for inducing more medical complications than the sampling of only one lung. A prospective study is needed to assess the possible risks of bilateral sampling for patients with suspected VAP. However, if bilateral BAL significantly im-proves the accuracy of the microbiologic diagnosis of VAP, then the benefits may outweigh the additional risks and costs.
Histological and bacteriological analyses have shown that VAP is often bilateral, multifocal, and predominant in the dependent lung segments (10, 13) . However, the necessity of bilateral as opposed to unilateral sampling for the accurate diagnosis of VAP is still debated. The twofold purpose of diagnostic testing is to confirm the presence of suspected pneumonia and to accurately identify the etiologic agents of disease (6) . In this retrospective study involving 287 mechanically ventilated patients, we determined the concordance between leftand right-lung BAL cultures for the microbiological diagnosis of VAP. We also investigated the utility of unilateral sampling of either the left or the right lung, as well as the utility of pooling bilateral samples for a single culture, for detecting the causative bacterial agents of VAP. Our study shows that preferential sampling of the right lung improves the diagnostic accuracy of unilateral BAL. If bilateral sampling is performed, pooling of bilateral samples for a single quantitative culture is comparable to the processing of left-and right-lung samples separately. Chest radiograph interpretation, specimen collection, and specimen processing. A portable chest radiograph was taken prior to, and on the same day as, bronchoscopic sampling. The radiograph was reviewed and interpreted by a staff radiologist. Bronchoscopic BAL specimens were collected by physicians by wedging the tip of a fiber optic bronchoscope into a segment of the airway, sequentially instilling sterile physiologic saline, and aspirating each aliquot. Although the BAL collection procedure at our institution is not completely standardized, clinicians typically discarded the first aliquot and pooled the remaining fluid for microbiological analysis. This procedure was repeated in the contralateral lung, and samples were maintained at ambient temperatures or 4°C before being transported to the microbiology laboratory within 2 h of collection.
MATERIALS AND METHODS

Study
Quantitative cultures were processed by medical technologists according to the standard laboratory protocol. Sample pairs collected between 1 July 2002 and 12 July 2004 (n ϭ 160) were diluted in tryptic soy broth, plated at final dilutions of 10 Ϫ4 and 10 Ϫ5 onto eosin methylene blue agar, chocolate agar, and blood agar (tryptic soy agar with 5% sheep blood; Remel, Lenexa, KS), and incubated at 35°C under 5% CO 2 . Gram staining was performed on 1 drop of undiluted BAL fluid. Final colony counts were determined at 48 h. Potential pathogens present at Ն1 ϫ 10 5 CFU/ml were considered clinically significant, and subsequent identification and antimicrobial susceptibility testing were performed. Isolates detected at Ն1 ϫ 10 4 and Ͻ1 ϫ 10 5 CFU/ml were presumptively identified, and antimicrobial susceptibility testing was not performed.
Sample pairs obtained between 13 July 2004 and 31 June 2007 (n ϭ 239; data subset 1) were diluted in tryptic soy broth and plated at final dilutions of 10
Ϫ3
and 10 Ϫ4 on the media described above. Potential pathogens present at Ն1 ϫ 10 4 CFU/ml were considered clinically significant, and identification and antimicrobial susceptibility testing were performed. Isolates present at Ն1 ϫ 10 3 and Ͻ1 ϫ 10 4 CFU/ml were presumptively identified, and susceptibility testing was not performed. Because colony counts were recorded at Ն1 ϫ 10 4 CFU/ml prior to 13 July 2004, we were able to analyze the entire data set using the currently accepted diagnostic threshold of 1 ϫ 10 4 CFU/ml. Culture interpretation. For the purposes of this study, a potential pathogen was defined as a bacterial species that could be recovered using our culture method, including Staphylococcus aureus, Streptococcus pneumoniae, enteric gram-negative rods, Pseudomonas spp., Acinetobacter spp., Stenotrophomonas maltophilia, Haemophilus influenzae, Neisseria meningitidis, and Moraxella catarrhalis. Mycobacteria, Legionella spp., viruses, and fungi were excluded from this analysis. Furthermore, the presence of oropharyngeal commensals, such as viridans streptococci, coagulase-negative staphylococci, and Corynebacterium spp., was considered insignificant.
The presence of at least one potential pathogen at Ն1 ϫ 10 4 CFU/ml was diagnostic of VAP (11) . The utility of pooling left and right BAL sample pairs for a single quantitative culture verses two separate cultures was investigated. We calculated the CFU per milliliter of isolates which would have been recovered had equal volumes of left-and right-lung samples been pooled for a single culture. In addition, we compared quantitative culture results from BAL pairs in which at least one sample met the diagnostic criteria for VAP. Sample pairs were considered concordant if the cultures of both the left-and right-lung samples yielded the same pathogenic isolate(s) at significant concentrations (Ն1 ϫ 10 4 CFU/ml). Partial concordance was assigned if at least one but not all species were recovered at significant concentrations from both lungs. Total disagreement was designated if one lung was positive for significant growth of Ն1 pathogen while the contralateral lung was negative or if the lungs yielded different pathogens, each above the VAP threshold. Six positive bilateral samples contained gram-negative rods in both lungs, which were not further identified because they were detected at a concentration below the threshold considered clinically significant. Because 98.9% of sample pairs that had gram-negative rods above the diagnostic threshold in both lungs had the same species, we assumed the identity of these six pairs for statistical analysis. In subset 1 of the data (n ϭ 239), the threshold of detection was 1 ϫ 10 3 CFU/ml and the category of partial agreement included BAL pairs in which the same organism was recovered in both lungs but only one lung had a concentration of Ն1 ϫ 10 4 CFU/ml. Statistical analysis. The overall concordance between left-and right-lung BAL culture pairs for the detection of VAP was assessed by generating a kappa statistic. Similarly, we determined the accordance between bilateral BAL specimens pooled for a single quantitative culture verses bilateral BAL specimens processed separately. We calculated 95% confidence intervals (95% CI) to assess the probability that the left or right lung was positive for significant growth, given that the contralateral lung was positive. Similarly, we evaluated the probability that either the left or the right lung was negative, given that the contralateral lung was negative.
RESULTS
Underlying illness of patients and number of BALs. The medical records of 287 patients with suspected VAP who underwent bilateral bronchoscopic BAL were reviewed. Two hundred nine patients were males, and 78 were females, and the mean age was 45 years (range, 3 to 89 years). Trauma was the most common underlying illness (69%) ( Table 1) . One set of BAL pairs was collected from 211 patients, two sets from 52 patients, three sets from 16 patients, four sets from 3 patients, five sets from 3 patients, and seven sets from 1 patient. One patient had one right-lung and two left-lung BAL samples Concordance between left and right BAL sample pairs regarding the microbiological diagnosis of VAP. A total of 399 BAL sample pairs were obtained from 287 patients, 48.8% of whom had at least one episode of VAP (Table 2) . No evidence of bacterial infection was found in 226 BAL pairs (56.6%). Significant bacterial growth was detected in 173 of 399 BAL pairs (43.4%). Growth was defined as significant if at least one pathogen was detected at Ն1 ϫ 10 4 CFU/ml. Among positive BAL pairs, 141 (81.5%) had significant growth in both lung samples. In contrast, growth was unilateral in 32 sample pairs (18.5%), 11 (6.4%) with growth in the left lung and 21 (12.1%) with growth in the right lung.
Concordance between BAL sample pairs regarding the diagnosis of VAP was also subdivided according to the underlying illness of the patient at the time of bronchoscopic sampling ( Table 2) . Among positive BAL specimens from trauma patients (n ϭ 141), 113 sample pairs had significant bacterial growth bilaterally while 28 had unilateral growth, 11 in the left lung and 17 in the right lung. Among positive BAL specimens from nontrauma patients (n ϭ 32), 28 had significant bacterial growth bilaterally while 4 sample pairs had unilateral growth, only in the right lung. Including both positive and negative culture pairs, concordance was 90.4% for trauma patients, 96.3% for nontrauma patients, and 92% for all combined.
Correlation between culture results and chest radiographs for subjects with unilaterally positive sample pairs. Unilateral growth was detected by quantitative culture in 32 sample pairs. The quantitative culture results were compared to radiographic findings from portable chest X rays obtained from the patients prior to sampling (Table 3 ). Bilateral airspace disease or bilateral opacities were detected in 12 of 32 (37.5%) chest radiographs. Abnormalities were attributed to noninfectious processes, such as atelectesis, in six radiographs, and no abnormalities were detected in four radiographs. Among the remaining seven sample pairs unilaterally positive in the left lung, abnormalities were detected solely on the left side in four chest radiographs and solely on the contralateral side in three radiographs. Among the remaining three sample pairs unilaterally positive in the right lung, abnormalities were detected solely on the right side in one chest radiograph and solely on the contralateral side in two radiographs.
Isolation of bacteria from left-and right-lung BAL samples. A total of 405 bacterial isolates were recovered, 197 from left-lung samples and 208 from right-lung samples (Table 4) . Table 4 shows the identity and concentration (e.g., 10 4 , 10 5 , or Ն10 6 CFU/ml) of bacteria recovered from left-and right-lung BAL specimens. The most frequently recovered bacterium was Staphylococcus aureus (27.6%), including methicillin-resistant Staphylococcus aureus (6.2%). Staphylococcus aureus was detected in 53 left-lung and 59 right-lung samples. Other major Table 5 summarizes the total number and combined concentrations of isolates found in left-and right-lung samples. There were 152 and 162 left-and right-lung-positive BAL specimens, respectively. A single isolate was recovered from 114 left-lung and 125 rightlung samples. Two or more isolates were recovered from 38 and 37 left-and right-lung samples, respectively. Among BAL pairs with significant unilateral bacterial growth, a single isolate was recovered from 11 left-lung-positive samples and 20 right-lung-positive samples. An additional sample had Ͼ1 pathogen unilaterally recovered from the right lung. The total concentrations of bacteria were between 1 ϫ 10 4 and 9 ϫ 10 5 CFU/ml in 65.1% and 66.7% of left-and right-lung-positive BAL specimens, respectively. The remainder of the positive samples had colony counts of Ն1 ϫ 10 6 CFU/ml. In contrast, 90.9% of unilateral left-lung-and 90.5% of unilateral rightlung-positive samples had total concentrations of bacteria between 1ϫ 10 4 and 9 ϫ 10 5 CFU/ml. In summary, BAL sample pairs with unilateral growth were more likely to be monomicrobial and to have bacterial growth detected at Ͻ1 ϫ 10 6 CFU/ml.
Utility of unilateral sampling of either the left or the right lung for the diagnosis of VAP. The kappa coefficient for VAP diagnosis between culture-positive bilateral BAL specimens was 0.83 (95% CI, 0.78 to 0.89). A kappa coefficient of Ͼ0.75 indicates an excellent level of agreement between the left-and right-lung results. Furthermore, if the left-lung sample was diagnostic of VAP, the probability that the right lung was also on September 12, 2017 by guest http://jcm.asm.org/ positive was 92.8% (95% CI, 88.6% to 96.9%). Given that the right lung was positive, the likelihood that the left lung was also positive was 87% (95% CI, 81.9% to 92.2%). Similarly, if the left lung was negative, the probability that the right lung was also negative was 91.5% (95% CI, 88% to 94.5%); given that the right lung was negative, the likelihood that the left lung was also negative was 95.4% (95% CI, 92.7% to 98%). These values showed that although bilateral samples had a high level of concordance, the right-lung sample was a better predictor of the presence or absence of VAP. In order to determine the utility of preferential unilateral sampling of either the left or the right lung, we compared the concordance between significant concentrations of individual bacterial species detected in bilateral lung specimens and those found unilaterally. All bacterial species recovered from the left-and/or right-lung samples were detected in the right-lung samples of 154 positive BAL sample pairs (89%). At least one but not all species were detected in the right-lung samples of eight pairs (4.6%), and 11 right-lung samples (6.4%) were falsely negative. Therefore, unilateral sampling of the right lung would have failed to recover one or more significant bacterial species in 11% of positive BAL sample pairs. All bacteria recovered from the left-and/or right-lung samples were detected in the left-lung samples of 144 (83.2%) positive BAL sample pairs. At least one but not all species were recovered from the left lungs of eight (4.6%) pairs, and 21 (12.1%) left-lung BAL samples were falsely negative. Unilateral sampling of the left lung would have failed to recover one or more significant species in 16.7% of positive BAL sample pairs.
Effect of combining data from left-and right-lung BAL samples. We also evaluated the implications of pooling equal volumes of the left-and right-lung samples for a single quantitative culture rather than processing each sample separately. The kappa coefficient for VAP diagnosis was 0.96 (95% CI, 0.94 to 0.99). In 160 (92.5%) of the 173 positive BAL sample pairs, all pathogens recovered at significant concentrations from the left-and/or right-lung samples would have been detected in a pooled sample. At least one but not all species would have been recovered in six pooled samples (3.5%), and seven samples (4%) would have been falsely negative. Of the seven false negatives, all were monomicrobial, with bacterial species recovered at the lowest concentration considered significant (1 ϫ 10 4 CFU/ml): Staphylococcus aureus was the most commonly recovered isolate (n ϭ 4).
DISCUSSION
Our results show that preferential sampling of the right lung improves the efficacy of unilateral BAL for the diagnosis of VAP over that of left-lung sampling. A high level of agreement ( ϭ 0.83) was found between the culture results from left-and right-lung BAL samples in relation to the bacteriological detection of VAP. However, sole use of the right-lung sample would have resulted in fewer false negatives than sole use of the left-lung sample. Individual isolates detected at significant concentrations in bilateral sample pairs were more frequently detected in the right-lung sample. Additionally, we showed that pooling left-and right-lung samples for a single quantitative culture did not alter the efficacy of VAP detection that was achieved by processing left-and right-lung samples separately.
Our results indicated that pathogens at Ն1 ϫ 10 4 CFU/ml were more often recovered from the right-lung sample. This finding may be related in part to anatomical differences between the left and right lungs. For example, the right mainstem bronchus of the trachea is wider, shorter, and more vertical in direction than the left and enters the root of the right lung an inch higher than the left bronchus (14) . In general, the right mainstem bronchus appears to be a more direct continuation of the trachea than the left, which may partially explain why the right lung is more prone to infection. These anatomical differences may explain why our data showed that the right-lung sample was a better predictor of the presence or absence of VAP.
The importance of identifying all clinically significant bacterial species in order to ensure appropriate antimicrobial treatment of VAP cannot be overstated. The primary purpose of quantitative culture of BAL fluid is to identify potential pathogens and determine their antimicrobial susceptibility patterns. This information allows clinicians to de-escalate the initial empirical regimen if bacterial agents of VAP are detected or to discontinue therapy in the absence of VAP. Jackson et al. (5) compared quantitative culture results of bilateral BAL samples from 73 critically ill surgical patients with suspected VAP and showed that the sole use of unilateral sampling to guide therapy would have resulted in inappropriate avoidance and/or discontinuation in 25% of VAP positive patients studied. Our results showed that all pathogens recovered at significant concentration from bilateral sample pairs would have been detected in a unilateral right lung sample in 89% of positive sample pairs. Unilateral sampling would have failed to recover one or more significant isolates in 11% of positive pairs had only the right lung been sampled and in 16.7% had only the left lung been sampled. Unilateral sampling may have resulted in inadequate therapy or inappropriate discontinuation or avoidance of antimicrobial therapy in these instances.
Among positive BAL sample pairs, 12.1% of left lung samples and 6.4% of right lung samples were falsely negative. We reviewed the chest radiographs from patients with unilateral positive BAL cultures in order to determine the correlation between radiographic findings and bacterial culture results. We found that 36.4% of unilateral left lung positive BAL pairs had corresponding chest radiographs showing abnormalities solely on the left side. Previous studies have shown that the chest radiograph is unreliable for determining the site of infection in the lungs. Jackson et al. (5) showed that the influence of the chest radiograph was equivocal because of the presence of bilateral infiltrates in 80% of discordant samples. Our results, however, suggest that if a left-lung abnormality is seen on the chest radiograph, the clinician should consider sampling the left lung in addition to the right in order to maximize the sensitivity of quantitative BAL culture for the detection of VAP.
In order to further characterize the patterns of bacterial growth in both discordant and partially discordant BAL sample pairs, we analyzed a subset of the data for which the threshold of detection was 1 ϫ 10 3 CFU/ml (data not shown). We found that the percentage of BAL sample pairs displaying total disagreement was considerably lower, while the percentage displaying partial agreement was higher, than those of the entire data set when insignificant concentrations were not consid- ered. This result indicates that the individual species found at a significant concentration in one lung may often be present in an insignificant but detectable concentration in the contralateral lung. Studies have shown that secretions from an infected lung contain 10 5 CFU/ml, and the concentration of bacteria is diluted 10-to 100-fold in BAL fluid (7) . A quantitative culture result of 10 4 CFU/ml should consequently represent 10 5 to 10 6 bacteria per ml of lung secretions. Because the concentration of bacteria in BAL fluid is only an estimate of the actual bacterial burden in the lung, no diagnostic threshold can predict infection with 100% accuracy. The frequency of unilateral infection detected in our study may not be applicable to all patient groups. A previous study of bilateral BAL samples from 94 ARDS patients with suspected VAP showed that pathogens were found at significant concentrations in only one lung in 60% of positive bronchoscopies (8) . Conversely, our study found that infection was unilateral in 18.5% of positive BAL sample pairs. One possible explanation for such a large discrepancy between these findings is that the majority of subjects included in our study were trauma patients. Male gender and trauma admission are among the independent risk factors for VAP (9) . In our study, the number of subjects in nontrauma subpopulations was small. Nevertheless, unilateral sampling of the right lung for nontrauma patients would have detected bacteria at significant concentrations in 100% of bilaterally positive BAL sample pairs. Further investigation is needed to determine if the patient's underlying illness should be considered in choosing a strategy for the detection of VAP by quantitative culture of BAL fluid. Due to the large sample size of our study and the predominance of males and trauma patients, we believe that our findings are particularly applicable to trauma patients with suspected VAP.
While several recent studies have investigated the utility of bilateral BAL for the diagnosis of VAP, the option of pooling left-and right-lung samples for a single quantitative culture has not been adequately addressed. While pooling would not spare the patient the costs and risks associated with the bronchoscopic collection of bilateral BAL samples, the patient would incur the cost of only one rather than two quantitative cultures. At our institution, the processing charge for a BAL culture is $61.95, and the patient incurs additional charges for each significant isolate recovered, e.g., $45.26 for identification and antimicrobial susceptibility testing of Staphylococcus aureus. We found a very high concordance between pooled and individual left-and right-lung cultures regarding the detection of significant bacterial growth ( ϭ 0.96). In relation to the detection of individual pathogens, pooling equal volumes of BAL fluid from left-and right-lung samples for culture was comparable to processing left-and right-lung samples individually (92.5%). In theory, pooling would have failed to find only those isolates present unilaterally at Յ1 ϫ 10 4 CFU/ml. If bilateral BAL is performed, we recommend pooling left-and right-lung samples for a single culture as a cost saving measure.
Retrospective data collection resulted in several limitations to our methods. We were unable to compare microbiological results to a "gold standard" such as histological analysis for the confirmation of infection. In a clinical setting, such a comparison would be restricted by ethical concerns. Furthermore, the precise method of bronchoscopic BAL collection is not standardized at our institution. Variability in both the amount of BAL fluid injected and the amount aspirated during BAL collection may have had some effect on our results. Further investigation is needed to better understand the influence of BAL fluid volumes on the level of agreement between left-and right-lung culture results. Although the timing and order of BAL sample collection were not documented, a similar study found no correlation between timing and order in the frequency of sample discordance (5) . Other technical factors, such as the selection of the sampling site, the presence of airway obstruction, and the adequacy of segmental wedging of the bronchoscope, may also have influenced our microbiological results (16) . Some aspects of subject history, such as recent antibiotic therapy and number of ventilator days, were not considered, and their impact on our data is not known. Retrospective data collection did, however, allow us to study a large number of subjects over a 5-year period. Despite the potential limitations, our investigation provides valuable information regarding the efficacy of bilateral and unilateral BAL for the diagnosis of VAP in a clinical setting.
Accurate and timely identification of the bacterial species associated with VAP allows clinicians to determine appropriate antimicrobial treatment and subsequently to improve patient outcome. While inappropriate therapy may fail to resolve infection, unnecessary antimicrobial therapy may result in increased costs, the selection of resistant organisms, and adverse drug events. However, bronchoscopic sampling is costly and requires highly trained personnel to perform the procedure. In general, our findings suggest that the right lung should be preferentially sampled in order to improve the accuracy of unilateral BAL for the diagnosis of VAP. If bilateral sampling is preferred, our study also indicates that pooling bilateral BAL fluid for culture provides definitive microbiological results while significantly reducing patient costs. In summary, our results show that unilateral right-lung sampling may be an acceptable alternative to bilateral sampling for the detection of the etiologic agents of VAP in mechanically ventilated trauma patients.
